It binds through an RGD sequence to endothelial cells, and is frequently found localized with endothelial cells.48 Here, despite an increase of the endothelial cell marker, CD31, with VEGF overexpression, FN1, in viable tumor regions, significantly decreased. This evidence concerns the gene FN1 and neoplasm.